DNLIDenali Therapeutics Inc.

$22.08

What is the market doing?

What the tape says about DNLI

Denali Therapeutics Inc. is +49% over the past year while the S&P 500 is +20%: 29 points ahead of the market.

+49%

1-year return · S&P 500 +20%

vs 200-day average
+8.9%

vs 200-day average · close to trend

RSI (14)
33

RSI (14) · neutral

Below its 52-week high
17%

Below its 52-week high

2024-08-15$11.47 – $31.58 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$22.08
1 monthS&P 500 −0.30%
−11%
1 yearS&P 500 +20%
+49%
5 yearsS&P 500 +85%
−58%
vs 50-day average$23.72
−6.9%
52-week high
$26.48
52-week low
$12.75
Annualised volatility
60%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$865K
Calendar-year price return
YearReturn
2026 (year to date)+34%
2025−19%
2024−5.0%
2023−23%
2022−38%
2021−47%
2020+381%
2019−16%
2018+32%
Average return by calendar month, 2017–2026
MonthYearsPositiveAverage
Jan95 of 9+6.9%
Feb93 of 9−2.3%
Mar92 of 9−8.8%
Apr95 of 9+0.77%
May97 of 9+5.6%
Jun96 of 9+7.3%
Jul93 of 9−4.4%
Aug95 of 9+5.8%
Sep94 of 9+1.2%
Oct83 of 8−3.7%
Nov85 of 8+14%
Dec83 of 8+1.1%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.